Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 620

1.

Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus.

Zur E.

Int J Pharm Compd. 2019 Sep-Oct;23(5):376-381.

PMID:
31513535
2.

Topical sucralfate cream treatment for aplasia cutis congenita with dystrophic epidermolysis bullosa: a case study.

Yaşar Ş, Yaşar B, Cebeci F, Bayoğlu D, Nuhoğlu Ç.

J Wound Care. 2018 Nov 2;27(11):768-771. doi: 10.12968/jowc.2018.27.11.768.

PMID:
30398936
3.

ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats.

Marks SL, Kook PH, Papich MG, Tolbert MK, Willard MD.

J Vet Intern Med. 2018 Nov;32(6):1823-1840. doi: 10.1111/jvim.15337. Epub 2018 Oct 31.

4.

A pilot study investigating the in vitro efficacy of sucralfate against common veterinary cutaneous pathogens.

Yen T, Boord MJ, Ghubash R, Blondeau JM.

J Small Anim Pract. 2018 Nov;59(11):691-694. doi: 10.1111/jsap.12902. Epub 2018 Jul 4.

PMID:
29972242
5.

Effectiveness of Topical Sucralfate in the Management of Pressure Ulcer in Hospitalized Patients: A Prospective, Randomized, Placebo-Controlled Trial.

Ala S, Saeedi M, Gholipour A, Ahmadi M, Asoodeh A, Shiva A.

Am J Ther. 2019 Jan/Feb;26(1):e5-e11. doi: 10.1097/MJT.0000000000000531.

PMID:
29642075
6.

Endoscopic Management of Recalcitrant Marginal Ulcers by Covering the Ulcer Bed.

Barola S, Fayad L, Hill C, Magnuson T, Schweitzer M, Singh V, Chen YI, Ngamruengphong S, Khashab MA, Kalloo AN, Kumbhari V.

Obes Surg. 2018 Aug;28(8):2252-2260. doi: 10.1007/s11695-018-3162-7.

PMID:
29556889
7.

Effect of sucralfate on gastric permeability in an ex vivo model of stress-related mucosal disease in dogs.

Hill TL, Lascelles BDX, Blikslager AT.

J Vet Intern Med. 2018 Mar;32(2):670-678. doi: 10.1111/jvim.15076. Epub 2018 Feb 20.

8.

Continuous radiotelemetric monitoring of intragastric pH in a dog with peptic ulceration.

Lane MB, Larson JC, Stokes JE, Tolbert MK.

J Am Vet Med Assoc. 2017 Mar 1;250(5):530-533. doi: 10.2460/javma.250.5.530.

PMID:
28207313
9.

A distinct microbiota composition is associated with protection from food allergy in an oral mouse immunization model.

Diesner SC, Bergmayr C, Pfitzner B, Assmann V, Krishnamurthy D, Starkl P, Endesfelder D, Rothballer M, Welzl G, Rattei T, Eiwegger T, Szépfalusi Z, Fehrenbach H, Jensen-Jarolim E, Hartmann A, Pali-Schöll I, Untersmayr E.

Clin Immunol. 2016 Dec;173:10-18. doi: 10.1016/j.clim.2016.10.009. Epub 2016 Oct 24.

10.

Complementarity of in vitro and in vivo models for the evaluation of gastro-protective effects of pharmacological substances.

Goineau S, Castagné V.

Fundam Clin Pharmacol. 2017 Apr;31(2):155-164. doi: 10.1111/fcp.12248. Epub 2016 Nov 23.

PMID:
27739140
11.

Bariatric Embolization: Pilot Study on the Impact of Gastroprotective Agents and Arterial Distribution on Ulceration Risk and Efficacy in a Porcine Model.

Paxton BE, Arepally A, Alley CL, Kim CY.

J Vasc Interv Radiol. 2016 Dec;27(12):1923-1928. doi: 10.1016/j.jvir.2016.07.021. Epub 2016 Oct 4.

PMID:
27717647
12.

Antiseptics and Antibiotics for Surgical Wounds Healing by Secondary Intention: Summary of a Cochrane Review.

Norman G, Dumville JC, Crosbie EJ.

JAMA Dermatol. 2016 Nov 1;152(11):1266-1268. doi: 10.1001/jamadermatol.2016.3131. Review.

PMID:
27681006
13.

Clinical Drug-Drug Pharmacokinetic Interaction Potential of Sucralfate with Other Drugs: Review and Perspectives.

Sulochana SP, Syed M, Chandrasekar DV, Mullangi R, Srinivas NR.

Eur J Drug Metab Pharmacokinet. 2016 Oct;41(5):469-503. doi: 10.1007/s13318-016-0335-4. Review.

PMID:
27086359
14.

Acute Erosive Esophagitis As a Rare Complication of Severe Pediatric Diabetes Ketoacidosis.

Uysal S, Kerur B, Shapiro JM, Snelling LK, Quintos JB.

J Pediatr Gastroenterol Nutr. 2016 Apr;62(4):e38-9. doi: 10.1097/MPG.0000000000001086. No abstract available.

PMID:
27010401
15.

Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs.

KuKanich K, KuKanich B, Guess S, Heinrich E.

J Vet Intern Med. 2016 Jan-Feb;30(1):108-15. doi: 10.1111/jvim.13796. Epub 2015 Dec 9.

16.

Novel self-assembled mesalamine-sucralfate complexes: preparation, characterization, and formulation aspects.

Ispas-Szabo P, Friciu MM, Nguyen P, Dumoulin Y, Mateescu MA.

Drug Dev Ind Pharm. 2016;42(7):1183-93. doi: 10.3109/03639045.2015.1118493. Epub 2015 Dec 15.

PMID:
26574144
17.

Tissue content of sulfomucins and sialomucins in the colonic mucosa, without fecal stream, undergoing daily intervention with sucralfate.

Bonassa CE, Pereira JA, Campos FG, Rodrigues MR, Sato DT, Chaim FD, Martinez CA.

Acta Cir Bras. 2015 May;30(5):328-38. doi: 10.1590/S0102-865020150050000004.

18.

Black oesophagus.

Lin MC, Chu HC, Chen PJ.

QJM. 2015 Oct;108(10):839-40. doi: 10.1093/qjmed/hcv075. Epub 2015 May 13. No abstract available.

PMID:
25972352
19.

Diosmin protects against ethanol-induced gastric injury in rats: novel anti-ulcer actions.

Arab HH, Salama SA, Omar HA, Arafa el-SA, Maghrabi IA.

PLoS One. 2015 Mar 30;10(3):e0122417. doi: 10.1371/journal.pone.0122417. eCollection 2015.

20.

Addition of all-trans-retinoic acid to omeprazole and sucralfate therapy improves the prognosis of gastric dysplasia.

Jin J, Li X, Xing L, Chang Y, Wu L, Jin Z, Su X, Bai Y, Zheng Y, Jiang Y, Zhao X, Lu L, Gao Q.

J Int Med Res. 2015 Apr;43(2):204-16. doi: 10.1177/0300060514559791. Epub 2015 Jan 28.

PMID:
25631875

Supplemental Content

Loading ...
Support Center